A phase I dose-escalation study of danusertib (PHA-739358) administered as a 24-hour infusion with and without granulocyte colony-stimulating factor in a 14-day cycle in patients with advanced solid tumors.
Clin Cancer Res
; 15(21): 6694-701, 2009 Nov 01.
Article
em En
| MEDLINE
| ID: mdl-19825950
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Pirazóis
/
Benzamidas
/
Proteínas Serina-Treonina Quinases
/
Antineoplásicos
Limite:
Adult
/
Aged
/
Aged80
/
Female
/
Humans
/
Male
/
Middle aged
Idioma:
En
Ano de publicação:
2009
Tipo de documento:
Article